
Free Daily Podcast Summary
by Tensor Black
AI and Healthcare by TensorBlack is a clinician-led conversation about what artificial intelligence is actually doing in cancer care — and what it will take to deploy it, and to trust it. Sanjay Juneja, MD, is a triple board-certified hematologist and medical oncologist and VP of Clinical AI at Tempus AI. Douglas Flora, MD, LSSBB, is executive medical director of oncology services at St. Elizabeth Healthcare and editor-in-chief of the journal AI in Precision Oncology. Guests are among the most credible voices in oncology and AI: Eric Lefkofsky, founder and CEO of Tempus AI; Anant Madabhushi, PhD, of Emory University; and Scott Penberthy of Google — alongside cancer center executives, health-system leaders, health-policy attorneys, and the researchers publishing the underlying work. Conversations cover computational pathology and radiology, precision medicine and genomic sequencing, clinical decision support, digital twins, reimbursement and governance, drug discovery, and where the technology still falls short. Every episode works toward the same question: what does AI change in the clinic on Monday? Made for oncologists, cancer center and health system leaders, and the people deciding what to build, buy, validate, and deploy. The show launched in 2021 as the TARGET: Cancer Podcast, hosted by Sanjay Juneja, MD and Mika Newton, and became AI and Healthcare after 75 episodes.
The most recent episodes — sign up to get AI-powered summaries of each one.
What if medical scans we already collect contain signals that could predict cancer treatment response, reveal disease risk years earlier, or identify biological patterns the human eye cannot see? In this episode of AI & Healthcare, oncologists Dr. Sanjay Juneja and Dr. Doug Flora, speak with AI and biomedical imaging researcher Anant Madabhushi, PhD about the hidden information inside routine CT scans, retinal images, and pathology slides. They explore how AI could help predict treatment response, detect warning signs of disease, uncover meaningful signals in tumor vessels and surrounding tissue, and expand access in regions facing shortages of radiologists and pathologists. The conversation also examines explainability, automation bias, clinical validation, health equity, and the consequences of waiting too long to use potentially valuable technology. Anant Madabhushi, PhD is the Robert W. Woodruff Professor of Biomedical Engineering at Emory University and Georgia Tech and Executive Director of the Emory Empathetic AI for Health Institute. His work focuses on AI, radiomics, computational pathology, and predicting treatment response from routinely collected medical images. Subscribe for conversations about artificial intelligence, oncology, clinical medicine, and the future of healthcare.
Medicine is becoming too complex for any one clinician to keep up with alone. AI may soon change that equation. Dr. Francisco Esteva joins Dr. Sanjay Juneja and Dr. Doug Flora to explain how physicians can use AI to research faster, communicate more clearly with patients, automate repetitive work, and build systems that extend their expertise. Francisco began learning these tools around age 60. Today, he's building AI-powered workflows for patient education, YouTube, research, quality control, and automation. You don't have to become an AI expert. But understanding how to use these tools may soon become an essential clinical skill.
CMS just proposed rules that could decide who gets paid for AI in healthcare, and that's a bigger deal than another “better algorithm” story. Dr. Sanjay Juneja and Dr. Douglas Flora talk with Jordan Johnson (radiation oncology, healthcare finance, compliance and law) about what's actually in the proposal and what happens once it lands. Topics: when does AI actually count as a billable clinical service. Why getting paid also means getting watched more closely. Hospitals leaning toward integrated platforms over one-off point solutions. What to do now, before the rule locks in. Still just a proposal, not law yet, so we should say that somewhere.
Eric Lefkofsky, Founder and CEO of Tempus AI, joins Dr. Sanjay Juneja and Dr. Doug Flora to explore how artificial intelligence, real-world data, genomic sequencing, and emerging technologies like organoids are reshaping oncology. From reducing diagnostic errors to matching patients with more effective therapies, AI is transforming how clinicians make decisions and how researchers develop the next generation of treatments. The conversation examines why healthcare adoption has lagged behind technological progress, the growing role of patient-driven intelligence, and how connected data may help eliminate thousands of preventable cancer deaths each year. Eric also shares his vision for AI-powered clinical decision support, digital twins, drug development, and the future relationship between physicians and intelligent systems.
What happens when artificial intelligence becomes a trusted partner in patient care? Healthcare leaders are increasingly exploring how AI can help clinicians make faster, more informed decisions while reducing administrative burden and improving patient outcomes. But deploying AI in medicine requires balancing innovation, trust, regulation, and clinical judgment. In this conversation, Dr. Scott Penberthy, Dr. Lindsey Cotton, and Dr. Doug Flora explore the future of cancer care, precision medicine, digital twins, physician adoption, implementation science, and the role of AI in supporting—not replacing—clinical decision-making. From cancer screening and treatment selection to workflow automation and predictive modeling, they discuss what healthcare may look like when every clinician has access to intelligence that helps them see what was previously invisible.
Cancer is often most treatable when it's found early—but what if we could detect it before symptoms ever appear? Advances in genomics, blood-based biomarkers, and artificial intelligence are giving researchers new ways to identify cancer earlier, understand disease at a deeper level, and move beyond one-size-fits-all treatment approaches. In this conversation, Dr. Scott Penberthy, Dr. Lindsey Cotton, and Dr. Doug Flora explore how emerging technologies are reshaping cancer detection, precision medicine, drug discovery, and clinical decision-making. They discuss the growing role of multimodal AI, the promise of next-generation sequencing, and why the future of healthcare may depend on finding patterns humans simply cannot see on their own. The goal isn't just better technology—it's earlier intervention, more personalized care, and better outcomes for patients.
Cancer treatment may be missing one of the body’s most important biological signals: circadian rhythm. In this conversation, sleep neurologist Dr. Anne Marie Morse explains how sleep timing, inflammation, immune function, and wearable data could fundamentally reshape cancer care. Emerging research suggests the timing of immunotherapy, chemotherapy, and even sleep disruption itself may influence treatment response, survival, and recurrence risk. The discussion explores chronotherapy, circadian genes, microbiome interactions, and how AI-driven analytics may help clinicians move beyond episodic care toward continuous, personalized monitoring.
AI is transforming healthcare at an unprecedented pace—but the biggest risks aren’t clinical, they’re legal, operational, and systemic. From data center infrastructure and environmental impact to reimbursement shifts and agentic AI workflows, the stakes are rising fast. New models from major tech players are poised to influence care delivery—and even get reimbursed based on outcomes—raising critical questions about ownership, liability, and control. Where does responsibility fall when AI drives decisions? How should hospitals evaluate vendors, data sources, and infrastructure risks? And what happens when automation outpaces regulation?
Free AI-powered daily recaps. Key takeaways, quotes, and mentions — in a 5-minute read.
Get Free Summaries →Free forever for up to 3 podcasts. No credit card required.
Listeners also like.

AI and I
Interviews with professionals who use AI tools in their work, exploring how AI affects creativity, thinking, and daily life through live demonstrations.

OpenAI Podcast
Conversations with OpenAI researchers and builders exploring how frontier AI models are developed and used in practice.

The AI XR Podcast.
Industry insiders interview top founders and executives on AI, spatial computing, VR/AR, and synthetic media.

Eye On A.I.
A biweekly podcast exploring artificial intelligence through conversations with key figures shaping its development and global impact.

Everyday AI Podcast – An AI and ChatGPT Podcast
Practical AI and ChatGPT tips for professionals to improve productivity and grow their careers.

The Most Interesting Thing in AI
Conversations with leading thinkers exploring the ethical, economic, and social impact of artificial intelligence.

Building AI Boston
Discusses artificial intelligence through real-world applications and ethical considerations in Boston’s tech community.

No Priors: Artificial Intelligence | Technology | Startups
Discusses AI advancements and implications with researchers, engineers, and founders shaping the future of artificial intelligence.

80,000 Hours Podcast
Discusses artificial intelligence and global catastrophic risks with experts and researchers.

Latent Space: The AI Engineer Podcast
Explores AI engineering breakthroughs in foundation models, code generation, and AI agents through interviews with researchers and developers.

How I AI
A practical guide to using AI tools in work and life, featuring guests who share specific, actionable techniques and workflows.

AI For Humans: Weekly AI News, Tools & Trends
A weekly breakdown of major AI news, tools, and breakthroughs for both newcomers and seasoned enthusiasts.
AI and Healthcare by TensorBlack is a clinician-led conversation about what artificial intelligence is actually doing in cancer care — and what it will take to deploy it, and to trust it. Sanjay Juneja, MD, is a triple board-certified hematologist and medical oncologist and VP of Clinical AI at Tempus AI. Douglas Flora, MD, LSSBB, is executive medical director of oncology services at St. Elizabeth Healthcare and editor-in-chief of the journal AI in Precision Oncology. Guests are among the most credible voices in oncology and AI: Eric Lefkofsky, founder and CEO of Tempus AI; Anant Madabhushi, PhD, of Emory University; and Scott Penberthy of Google — alongside cancer center executives, health-system leaders, health-policy attorneys, and the researchers publishing the underlying work. Conversations cover computational pathology and radiology, precision medicine and genomic sequencing, clinical decision support, digital twins, reimbursement and governance, drug discovery, and where the technology still falls short. Every episode works toward the same question: what does AI change in the clinic on Monday? Made for oncologists, cancer center and health system leaders, and the people deciding what to build, buy, validate, and deploy. The show launched in 2021 as the TARGET: Cancer Podcast, hosted by Sanjay Juneja, MD and Mika Newton, and became AI and Healthcare after 75 episodes.
AI-powered recaps with compact key takeaways, quotes, and insights.
Get key takeaways from AI and Healthcare in a 5-minute read.
Stay current on your favorite podcasts without falling behind.
It's a free AI-powered email that summarizes new episodes of AI and Healthcare as soon as they're published. You get the key takeaways, notable quotes, and links & mentions — all in a quick read.
When a new episode drops, our AI transcribes and analyzes it, then generates a personalized summary tailored to your interests and profession. It's delivered to your inbox every morning.
No. Podzilla is an independent service that summarizes publicly available podcast content. We're not affiliated with or endorsed by Tensor Black.
Absolutely! The free plan covers up to 3 podcasts. Upgrade to Pro for 15, or Premium for 50. Browse our full catalog at /podcasts.
AI and Healthcare publishes biweekly. Our AI generates a summary within hours of each new episode.
AI and Healthcare covers topics including Technology. Our AI identifies the specific themes in each episode and highlights what matters most to you.
Free forever for up to 3 podcasts. No credit card required.
Free forever for up to 3 podcasts. No credit card required.